High-quality, reliable, and compliant medical writing services, guiding you from the very beginning to the very end of your trial.
To ensure compliance and a successful conduct of your trial, we can also develop training materials for investigative site staff.
We provide regulatory writing support for clinical development plans, clinical trial applications (CTA), investigational new drug (IND) applications, and regulatory responses, and more!
As a part of our medical writing services, we collaborate with medical, regulatory and operational experts to draft high-quality study protocols that meet timelines and scientific standards.
As your CRO, Indero gets to know your research goals, requirements and specifications. Then, our team of medical writers develop the exact documentation you need—accurate, compliant, and easy to understand. We prioritize proactive communication, quick turnarounds, and continuous support to keep your trial moving forward.
Scientific discipline. Operational efficiency. Clinical development expertise. Our end-to-end solution provides the rigorous foundation, quality data and expertise Dermatology & Rheumatology studies need to ensure effective execution and on-time delivery.
“Congratulations to the team for a very positive pre-IND meeting outcome! Your dedication, and well-executed plans have laid a strong foundation for our program. This success is a significant trust-building milestone with the agency. Thank you for your outstanding work!”
Founder and CEO
Alys Pharmaceuticals
Global Head of Project Management
Alys Pharmaceuticals
Wherever
You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
3530 Saint-Laurent Boulevard
Suite 300
Montreal, QC, H2X 2V1, Canada
© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
